Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Coloplast A/S is a Danish multinational company that specializes in the development and manufacture of medical devices and services. The company's core business operates within the healthcare sector, offering products and services that focus on ostomy care, urology, continence care, and wound and skin care. Founded in 1957 and headquartered in Humlebæk, Denmark, Coloplast has established a strong presence in numerous countries, serving healthcare professionals and patients around the globe. Its strategic positioning is supported by a commitment to innovation and close collaboration with healthcare professionals to ensure the efficacy and safety of its offerings. Coloplast's competitive strengths derive from its comprehensive product portfolio and strong expertise in chronic care solutions.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Coloplast A/SJohnson & Johnson
Last price
€65.32$263.81
Currency
EUR
USD
€15B$636B
39.8240.07
€1.64$6.58
0.550.21
€3.08$5.28
4.71%2.03%
Sector
HealthHealth
Employees
17,213138,200
Ticker
€COLOB$JNJ
Primary listing
XGATNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €COLOB or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.